ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NHI vs V // REVENUE GROWTH (YOY)

National Health Investors Inc. (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: NHI 4 — V 5
▲ REVENUE GROWTH (YOY) LEADER: NHI
revenue-growth
47.10%
revenue-growth
11.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NHI VS. V) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NHI V SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 9.30% 32.30% -23.00 V /roic <GO>
EV/EBITDA & P/E Valuation — 28.9x — TIE /valuation <GO>
Free Cash Flow Yield -1.75% 2.90% -4.65 V /fcf-yield <GO>
Operating Margin — 60.00% — TIE /operating-margins <GO>
Net Profit Margin 68.00% 50.10% +17.90 NHI /net-margins <GO>
Revenue Growth (YoY) ACTIVE 47.10% 11.30% +35.80 NHI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.16% 0.63% +4.53 NHI /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 9.09 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 9/9 -4.00 V /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.6 74.2 -15.60 V /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.06 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 19.4x 34.0x -14.60 NHI /forward-pe <GO>
Enterprise Scale & Market Cap $3.36B $760.28B -$756.92B V /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NHI REV V REV NHI GROSS % V GROSS % NHI FCF V FCF
FY 2025 $80.1M $40.00B — — -$57.5M $21.26B
FY 2024 $54.4M $35.93B — — $49.8M $18.33B
FY 2023 $48.8M $32.65B — — $184.4M $19.29B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NHI // BETA —
V // BETA 1.06